FLI1 and hematologic disorder: FLI1 is considered as a major driver of hematological malignancies.88 Li et al used a CRISPR/Cas9 gene editing system to deactivate the FLI1 gene, applying two sgRNAs targeting the exons 2 and 3 of this gene.